Front Bioeng Biotechnol
October 2021
Since the emergence of regenerative medicine and tissue engineering more than half a century ago, one obstacle has persisted: the creation of large-scale vascular tissue (>1 cm) to meet the clinical needs of viable tissue grafts but also for biological research applications. Considerable advancements in biofabrication have been made since Weinberg and Bell, in 1986, created the first blood vessel from collagen, endothelial cells, smooth muscle cells and fibroblasts. The synergistic combination of advances in fabrication methods, availability of cell source, biomaterials formulation and vascular tissue development, promises new strategies for the creation of autologous blood vessels, recapitulating biological functions, structural functions, but also the mechanical functions of a native blood vessel.
View Article and Find Full Text PDF